| CAS ID: | 198904-31-3 |
| Molecular Formula: | C38H52N6O7 |
| Molecular Weight: | 704.9 g/mol |
| Monoisotopic Mass: | 704.3897 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | REYATAZ | CGP-73547 | ATAZANAVIR | BMS-232632-05 | ATAZANAVIR SULFATE |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t29-,30-,31+,32+/m0/s1 | See All |
| InChI Key: | AXRYRYVKAWYZBR-GASGPIRDSA-N | |
| Smiles: | COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc2ccc(cc2)c3ccccn3)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT01908660 | Disease | Liver fibrosis |
| Phase | Status | Completed | |
| First Received | July 26, 2013 | Last Verified | November 11, 2015 |
| Sponsor | Valme University Hospital | ||
| PubChem: | 148192 |
| ChEMBL: | CHEMBL1163 |